Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields

BACKGROUND: The genomic and overall biologic landscape of glioblastoma (GB) has become clearer over the past 2 decades, as predictive and prognostic biomarkers of both de novo and transformed forms of GB have been identified. The oral chemotherapeutic agent temozolomide (TMZ) has been integral to st...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Manjari, Xiu, Joanne, Mittal, Sandeep, Zeng, Jia, Saul, Michelle, Kesari, Santosh, Azadi, Amir, Newton, Herbert, Deniz, Karina, Ladner, Katherine, Sumrall, Ashley, Korn, W Michael, Lou, Emil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270729/
https://www.ncbi.nlm.nih.gov/pubmed/35821680
http://dx.doi.org/10.1093/noajnl/vdac096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270729/
https://www.ncbi.nlm.nih.gov/pubmed/35821680
http://dx.doi.org/10.1093/noajnl/vdac096

Ejemplares similares